Victoza (liraglutide) a once-daily GLP-1 injection FDA-approved for type 2 diabetes in adults and pediatric patients aged 10 and older
Available from: Liao C, Liang X, Zhang X, Li Y (2023) The effects of GLP-1 receptor agonists on visceral fat and liver ectopic fat in an adult population with or without diabetes and nonalcoholic fatty liver disease: a systematic review and meta-analysis
By embracing these approaches , medical aestheticians can effectively leverage semaglutide to help patients achieve and maintain their aesthetic and health goals
It is used alongside diet and physical activity to support weight loss in adults living with overweight or obesity under medical supervision
A smaller subset of users explore extended dosing during the maintenance phase after achieving significant weight loss, seeking a more affordable approach to sustaining results
Accessed January 15, 2026